Cargando…
In Silico Identification of Structure Requirement for Novel Thiazole and Oxazole Derivatives as Potent Fructose 1,6-Bisphosphatase Inhibitors
Fructose 1,6-bisphosphatase (FBPase) has been identified as a drug discovery target for lowering glucose in type 2 diabetes mellitus. In this study, a large series of 105 FBPase inhibitors were studied using a combinational method by 3D-QSAR, molecular docking and molecular dynamics simulations for...
Autores principales: | Hao, Ming, Zhang, Xiaole, Ren, Hong, Li, Yan, Zhang, Shuwei, Luo, Fang, Ji, Mingjuan, Li, Guohui, Yang, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3233463/ https://www.ncbi.nlm.nih.gov/pubmed/22174657 http://dx.doi.org/10.3390/ijms12118161 |
Ejemplares similares
-
Fructose 1,6-bisphosphatase: getting the message across
por: Timson, David J.
Publicado: (2019) -
Clinical and Molecular Characterization of Patients with Fructose 1,6-Bisphosphatase Deficiency
por: Li, Niu, et al.
Publicado: (2017) -
The Role of Liver Fructose-1,6-Bisphosphatase in Regulating Appetite and Adiposity
por: Visinoni, Sherley, et al.
Publicado: (2012) -
A Chinese Adult Patient with Fructose 1,6-bisphosphatase Deficiency
por: Lu, Jing-Ru, et al.
Publicado: (2017) -
Regulation of Fructose 1,6-Bisphosphatase in Procyclic Form Trypanosoma brucei
por: Wilkinson, Christina, et al.
Publicado: (2021)